Canertinib (Base):
N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide ; CAS : 267243-28-7 ; C24H25ClFN5O3 ; Exact Mass: 485.1630 ; |
Canertinib 4,6-Diamino Impurity:
7-(3-Morpholinopropoxy)quinazoline-4,6-diamine ; C15H21N5O2 ; MW: 303.36 ; |
Canertinib 4-Amino Impurity:
N-(4-Amino-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide ; C18H23N5O3 ; MW: 357.41 ; |
Canertinib Diaminoquinazolinol Impurity :
4,6-Diaminoquinazolin-7-ol ; C8H8N4O ; MW: 176.18 ; |
Canertinib Dihydrochloride:
CAS : 289499-45-2 ; C24H27Cl3FN5O3 ; Exact Mass: 557.1164 ; |
Canertinib N-Despropenyl Impurity :
N4-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazoline-4,6-diamine ; CAS : 267243-68-5 ; C21H23ClFN5O2 ; MW: 431.89 ; |
Canertinib Nitro Impurity :
N-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)-6-nitroquinazolin-4-amine ; CAS : 267243-64-1 ; C21H21ClFN5O4 ; MW: 461.87 ; |